Ultimately, this study was shown to have limitations, but was credited with starting the wave of tight glucose control ICU algorithms, which appeared poised to engulf intraoperative glycemic management. This investigation compared controlling blood glucose between 80 and 110 mg/dL to a conventional treatment group (starting insulin infusions when the glucose was greater than 215 mg/dL).
4.6% at 12 months) and morbidity in a surgical intensive care unit (ICU) population dominated by cardiac surgical patients. Van den Berghe’s group 2 reported reduced mortality (8 vs.
#Is dll care safe trial
In particular, the single-center intensive insulin therapy trial from Dr. 1 Studies such as this and others that reported changes in patient outcomes secondary to controlling perioperative glucose concentrations drove increased blood glucose monitoring in the acute care setting. Hyperglycemia, defined in one study as 2 or more episodes of either a fasting glucose of 126 mg/dL or a random reading of 200 mg/dL, or greater, was shown to be a strong predictor of in-hospital mortality. We believe that the technology we use in our practice has not only been thoroughly vetted by monitor and device manufacturers and the FDA, but also by academic physicians who have tested, compared these technologies to other systems, and published the results. Anesthesia care providers rely heavily on monitors and diagnostic devices for the safe passage of our patients.
0 kommentar(er)
